Literature DB >> 11766992

Fractalkine induces chemotaxis and actin polymerization in human dendritic cells.

S Dichmann1, Y Herouy, D Purlis, H Rheinen, P Gebicke-Härter, J Norgauer.   

Abstract

OBJECTIVE AND
DESIGN: Dendritic cells (DCs) are considered as the principle initiators of immune responses by virtue of their ability to migrate into target sites, process antigens and activate naive T cells. Here, the chemotactic activity and intracellular signaling of fractalkine was analyzed and compared to well known chemotaxins.
METHODS: The mRNA-expression of G protein-coupled CX3CR1 was analyzed by RT-PCR. Chemotaxis was measured in 48-well Boyden chambers and actin polymerization by flow cytometry.
RESULTS: The mRNA-expression of CX3CR1 in immature and mature DCs was revealed. Fractalkine elicited actin polymerization and chemotaxis in a dose-dependent manner in DCs independent of their state of maturation.
CONCLUSIONS: These results show that immature and mature DCs express mRNA for the CX3CRI and that fractalkine induces chemotaxis and migration associated actin polymerization in immature as well as in mature DCs, contrasting with the action of other chemokines such as RANTES or MIP-3beta which act only on distinct maturation states of DCs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11766992     DOI: 10.1007/PL00000230

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  17 in total

1.  Enhanced disease and pulmonary eosinophilia associated with formalin-inactivated respiratory syncytial virus vaccination are linked to G glycoprotein CX3C-CX3CR1 interaction and expression of substance P.

Authors:  Lia M Haynes; Les P Jones; Albert Barskey; Larry J Anderson; Ralph A Tripp
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

2.  Tissue-specific differential antitumour effect of molecular forms of fractalkine in a mouse model of metastatic colon cancer.

Authors:  S Vitale; B Cambien; B F Karimdjee; R Barthel; P Staccini; C Luci; V Breittmayer; F Anjuère; A Schmid-Alliana; H Schmid-Antomarchi
Journal:  Gut       Date:  2006-07-26       Impact factor: 23.059

3.  Analyses of phenotypic and functional characteristics of CX3CR1-expressing natural killer cells.

Authors:  Isabell Hamann; Nadine Unterwalder; Astrid E Cardona; Christian Meisel; Frauke Zipp; Richard M Ransohoff; Carmen Infante-Duarte
Journal:  Immunology       Date:  2011-02-14       Impact factor: 7.397

Review 4.  Fractalkine (CX3CL1) and brain inflammation: Implications for HIV-1-associated dementia.

Authors:  R Cotter; C Williams; L Ryan; David Erichsen; A Lopez; H Peng; J Zheng
Journal:  J Neurovirol       Date:  2002-12       Impact factor: 2.643

5.  Silencing CX3CR1 production modulates the interaction between dendritic and endothelial cells.

Authors:  Xiaoyan Liu; Guohong Lu; Jinfang Shen
Journal:  Mol Biol Rep       Date:  2010-04-03       Impact factor: 2.316

6.  Enhanced recruitment of CX3CR1+ T cells by mucosal endothelial cell-derived fractalkine in inflammatory bowel disease.

Authors:  Miquel Sans; Silvio Danese; Carol de la Motte; Heitor S P de Souza; Brenda M Rivera-Reyes; Gail A West; Manijeh Phillips; Jeffry A Katz; Claudio Fiocchi
Journal:  Gastroenterology       Date:  2006-10-12       Impact factor: 22.682

Review 7.  The spreading of HIV-1 infection in the human organism is caused by fractalkine trafficking of the infected lymphocytes--a review, hypothesis and implications for treatment.

Authors:  Yechiel Becker
Journal:  Virus Genes       Date:  2007-04       Impact factor: 2.332

Review 8.  Leukocyte migration and graft-versus-host disease.

Authors:  Christian A Wysocki; Angela Panoskaltsis-Mortari; Bruce R Blazar; Jonathan S Serody
Journal:  Blood       Date:  2005-02-08       Impact factor: 22.113

9.  Macrophage/monocyte-specific deletion of Ras homolog gene family member A (RhoA) downregulates fractalkine receptor and inhibits chronic rejection of mouse cardiac allografts.

Authors:  Yianzhu Liu; Wenhao Chen; Chenglin Wu; Laurie J Minze; Jacek Z Kubiak; Xian C Li; Malgorzata Kloc; Rafik M Ghobrial
Journal:  J Heart Lung Transplant       Date:  2016-08-20       Impact factor: 10.247

10.  A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis.

Authors:  Ryan Ungaro; Masayuki Fukata; David Hsu; Yasmin Hernandez; Keith Breglio; Anli Chen; Ruliang Xu; John Sotolongo; Cecillia Espana; Julia Zaias; Greg Elson; Lloyd Mayer; Marie Kosco-Vilbois; Maria T Abreu
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-04-09       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.